Alnylam Pharmaceuticals Inc

NASDAQ: ALNY
$277.43
+$5.21 (+1.9%)
Closing Price on November 8, 2024

ALNY Stock Chart and Intraday Price

ALNY Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 19,220.62M USD
Shares Outstanding 125,946,000
Alnylam Pharmaceuticals Inc is a pioneering biopharmaceutical firm dedicated to the development and commercialization of innovative therapeutics based on RNA interference. The company's portfolio includes treatments for rare genetic conditions, such as hereditary transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria type 1, among others. Alnylam is also exploring treatments for a variety of other diseases, including hemophilia, hypercholesterolemia, and Alzheimer’s disease. Founded in 2002 and headquartered in Cambridge, Massachusetts, Alnylam has formed strategic partnerships with several leading pharmaceutical companies to advance its mission of transforming scientific discoveries into breakthrough therapies.

ALNY Articles

Monday's top analyst upgrades and downgrades included AbbVie, Adobe, Advance Auto Parts, Anheuser-Busch InBev, Bumble, Fortinet, Nike and Palo Alto Networks.
Tuesday's top analyst upgrades and downgrades included Advance Auto Parts, Alphabet, Biogen, Cheesecake Factory, Chesapeake Energy, Micron Technology, MongoDB, Ross Stores, Tesla and TG Therapeutics.
Monday's top analyst upgrades and downgrades included Apple, Atlassian, Block, CF Industries, Comerica, DraftKings, Exact Sciences, Global Payments, Kellogg, Mobileye Global, Shopify, VFC and Zions...
Monday's top analyst upgrades and downgrades included Adobe, Carvana, Goldman Sachs, Hudson Pacific Properties, Moderna, Take-Two Interactive Software and T-Mobile.
Wednesday's top analyst upgrades and downgrades included Block, Boeing, Cemex, Constellation Brands, FirstEnergy, Freeport-McMoRan, GoodRx, Hasbro, Kosmos Energy, PayPal, Shopify, Starbucks, Toast...
Thursday's top analyst upgrades and downgrades included Adobe, Carnival, Hyatt Hotels, Nio, Nvidia, RealReal, Starbucks, Tyson Foods and Vertex Pharmaceuticals.
Friday's top analyst upgrades and downgrades included Agnico-Eagle Mines, Biogen, Exelon, Meta Platforms, New York Times, PulteGroup, Snap and Vertex Pharmaceutical.
Monday afternoon's top analyst upgrades and downgrades included JetBlue Airways, Rocket Companies, Ross Stores, Sea, Southwest Airlines, Spirit Airlines, United Airlines, U.S. Bancorp and Wells Fargo.
Tuesday afternoon's top analyst upgrades and downgrades included EVgo, Luminar Technologies, Tencent Music Entertainment and Tesla.
Monday afternoon's analyst upgrades and downgrades included Activision Blizzard, BioMarin, eBay and Teladoc.
Monday's top analyst upgrades and downgrades included Akamai Technology, ContextLogic, DuPont de Nemours, First Solar, Peabody Energy, Southwest Airlines, 3M and Union Pacific.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Delta Airlines, Foot Locker, Nvidia and Petrobras.
Monday's top analyst upgrades and downgrades included American Eagle Outfitters, Baidu, GameStop, Halliburton, Mosaic, Regeneron Pharmaceuticals, Salesforce.com, Take-Two Interactive Software and...
Tuesday's top analyst upgrades and downgrades include Apple, Baidu, Boeing, Delta Air Lines, L3Harris Technologies, Moderna, Raytheon Technologies, Roku and Walt Disney.
Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe's, Noble Energy, PayPal, Square, Target and...